COVID-19 vaccination status quo

Since the beginning of the pandemic, the curtailment of SARS-CoV-2 has been attainable only through mobility-reducing measures (lockdowns), social distancing, and increased hygiene standards (e.g., wide usage of face masks). Vaccines are now offering hope to deescalate the pandemic without these strict measures.  As early as summer 2020, some potential vaccines cleared the rigid testing and licensure processes of national and international health authorities, a step which offered the concrete possibility of reaching a generalized immunity against COVID-19 and bringing the pandemic to an end.
As of February 2021, the mass vaccination campaigns have started in most parts of the world targeting to attain herd immunity against COVID-19 perhaps within 2021.
Statista is tracking the number of COVID-19 vaccines issued per day and comparing these figures with the average numbers needed for reaching herd immunity by the 31st of December 2021. With focus on the United States, United Kingdom, Germany, France, and Italy, the daily COVID-19 vaccines administrations in the first two countries are in sufficient quantities to reach herd immunity within 2021 year-end. By contrast, the EU countries should more than double the current number of daily vaccines' administration to reach the target.

Updated weekly. Last update: Feb. 22, 2021

For further insights on the pandemic:

• Economic downturn and recovery
• COVID-19 measures and their effects on mobility behavior

Find out the whole Statista reports' library on our Report shop!